Dr. Wang is an international leader in biomedical study of a group of small molecules of gas, known as gasotransmitters, a category which includes nitric oxide, carbon monoxide, and hydrogen sulfide (H2S). His research has been supported by Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering Research Council (NSERC) of Canada, Social Sciences and Humanity Research Council (SSHRC) of Canada, and the Heart and Stroke Foundation of Canada (HSF). Over the course of his career, Dr. Wang has received >$13M research funding. He has published 302 peer-reviewed papers in leading scientific journals and edited 3 books. His publications on H2S biology and medicine have received the highest total citations in this field in the world. He has been invited to give 173 lectures and keynotes around the world. To date, Dr. Wang has trained more than 125 graduate students, post-doctoral fellows, visiting scientists, and other research personnel.

Dr. Wang's achievements have been recognized with numerous honors and awards, including Top 25 Canadian Immigrants Award (2022), Fellow of Royal Society of Canada (2020), Fellow of the Canadian Academy of Health Sciences (2010), the Federation of Canadian Chinese Professionals Award of Merit (2017), Pfizer Senior Scientist Award of Canadian Society of Pharmacology and Therapeutics (2008), CIHR Investigator award (2000), Stevenson Visiting Professorship of Canadian Physiological Society (1996), and Canadian Cardiovascular Society Young Investigator Award (1995).